Gene Query: EPHA2

Dataset Description Geneva Score
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 122.33
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 113.01
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 100.69
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 96.76
RNA-seq analyisis of PUM2 knockout cells 88.91
Tracking of dCas9-methyltransferase footprints 87.14
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 83.49
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 83.12
CD95/Fas ligand mRNA is toxic to cells 81.57
Primary human trophoblast from term placenta 73.49
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 67.21
G-quadruplex structures mark human regulatory chromatin 62.57
DIGIT regulates endoderm differentiation of human embryonic stem cells 62.16
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 58.5
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 55.19
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 51.35
Mechanistic Model-Guided Study of Embryonic Morphogenesis 51.24
RNA-seq analyses of human prostate cancer cells 50.99
Characterization of the Merkel cell carcinoma miRNome 50.9
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 50.67
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 50.66
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 48.6
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 48.57
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 48.51
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 48.51
RNA-Seq analysis of breast cancer cells after shikonin treatment 48.41
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 48.14
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 48.12
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 47.76
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 47.12
Spliceosomal disruption of the non-canonical BAF complex in cancer 45.63
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 45.06
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 44.92
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 44.92
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 44.29
R430: A potent inbibitor of DNA and RNA viruses 43.99
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 43.69
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 43.67
High level DNA repair gene expression in human ES cells 43.21
Lipid degradation promotes prostate cancer cell survival 42.32
MYCi975 regulates MYC target genes 42.2
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 42.05
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 41.52
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 41.51
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 41.05
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 40.81
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 40.7
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 40.45
RNA-seq in transgenic cells 39.81
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 39.3
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 38.91
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 38.91
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 38.78
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 38.68
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 38.68
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 38.5
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 38.5
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 38.28
Maturation of human iNSCs 37.01
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 36.44
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 35.69
Transcriptome profiling of Normal and Cancerous Prostate Cells 35.4
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 35.06
Transcriptome analysis of Zika infected neural stem cells 34.23
Zika infected neural stem cells 34.23
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 34.11
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 33.76
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 33.16
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 32.78
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 31.9
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 31.75
Generation of trichogenic adipose-derived stem cells by expression of three factors 31.05
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 30.82
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 30.33
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 30.33
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 30.22
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 30.04
RNA-seq analysis to identify the genes regulated by p53-SET interplay 29.95
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 29.92
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 29.58
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 29.34
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 29.11
BET bromodomain inhibition 28.82
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 28.82
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 28.75
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 28.34
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 28.12
RNA sequencing analysis of human embryonic stem cells and axial progenitors 28.12
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 27.68
AMPK signaling for naïve pluripotency 27.58
AMPK signaling for naïve pluripotency [Hs] 27.58
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 27.48
PGE2 mediated gene expression changes in human cervical stromal cells 27.18
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 27.06
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 26.98
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 26.98
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 26.96
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 26.96
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 26.87
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 26.82
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 26.74
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 26.72
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 26.7
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 26.69
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 26.57
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 26.47
A prostate cancer chromatin interaction map 26.4
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 26.11
The MEF2B Regulatory Network 26.07
The MEF2B Regulatory Network - RNA-seq data 26.07
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 26.01
Differential expression of genes in AD169-infected MRC5. 25.79
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 25.55
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 25.27
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 25.27
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 25.27
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 25.16
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 25.16
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 25.02
Controlling for gene expression changes in transcription factor protein networks. 24.95
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 24.69
RNA sequencing of BT142 and TS603 cell lines 24.52
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 24.52
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 24.51
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 24.38
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 24.3
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 24.29
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 24.17
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 23.79
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 23.72
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 23.72
MEIS1 regulates hematopoiesis in hPSCs 23.65
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 23.47
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 23.24
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 23.12
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 22.94
Transcriptomic and gene ontology profiling of the human corneal cell types 22.87
Differential gene expression in Jagged1 treated human dental pulp cells. 22.75
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 22.62
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 22.62
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 22.46
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 22.33
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 22.31
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 22.07
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 22.07
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 21.88
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 21.63
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 21.62
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 21.58
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 21.58
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 21.45
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 21.34
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 21.3
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 21.28
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 21.27
Analysis of transcriptional regulation by Myt1 and Myt1l 21.25
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 21.16
Hepatitis C virus functionally sequesters miR-122 21.16
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 21.11
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 21.02
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 20.57
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 20.57
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 20.5
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 20.29
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 20.19
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 20.08
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 20.08
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 19.9
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 19.76
An RNA-centric dissection of host complexes controlling flavivirus infection 19.76
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 19.68
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 19.66
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 19.6
A549 cell transcriptome responses to infection with H7N9 influenza virus 19.48
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 19.25
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 19.24
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 19.17
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 19.17
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 19.16
A549 cells and MSR-A549 cells 19.16
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 18.92
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 18.81
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 18.77
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 18.77
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 18.71
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 18.65
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 18.65
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 18.64
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 18.59
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 18.57
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 18.43
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 18.43
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 18.4
Expression level comparison under dividing and quiescent states in human primary fibroblasts 18.35
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 18.31
MOF acetyl transferase regulates transcription and respiration in mitochondria 18.25
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 18.22
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 18.16
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 18.15
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 18.13
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 18.07
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 18.06
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 18.05
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 18.04
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 18.04
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 18.01
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 17.99
Genome wide expression change by RNF168 knocking down in NEC cells 17.97
NHLRC1 re-expression in cancer cells 17.93
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 17.92
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 17.76
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 17.73
Gene expression analysis of immortalized human liver progenitor-like cells in culture 17.69
High-Throughput Kinetic Analysis of Fractional Killing 17.67
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 17.45
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 17.3
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 17.27
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 17.27
Effect of FGF13 depletion on the H460 cell line 17.08
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 17.05
Identification of Sin3B regulated genes during quiescence 16.97
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 16.94
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 16.94
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 16.9
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 16.67
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 16.64
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 16.6
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 16.6
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 16.49
Cajal bodies are linked to genome conformation [RNA-Seq] 16.45
Cajal bodies are linked to genome conformation 16.45
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 16.43
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 16.34
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 16.32
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 16.31
Transcriptional profiling of LS1034 cells treated with tepoxalin 16.28
Electronic cigarettes 16.26
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 16.25
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 16.18
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 16.18
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 16.1
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 16.09
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 16.05
Androgen Receptor-regulated genes in prostate cancer cells 15.99
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 15.99
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 15.85
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 15.85
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 15.78
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 15.74
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 15.72
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 15.72
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 15.68
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 15.68
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 15.65
RNA Sequencing of three pairs of gastric cancer 15.58
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 15.54
Lineage specific differentiation is influenced by state of human pluripotency 15.5
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 15.5
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 15.38
mRNA-sequencing of breast cancer subtypes and normal tissue 15.31
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 15.3
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 15.3
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 15.3
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 15.29
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 15.29
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 15.23
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 15.04
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 14.99
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 14.99
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 14.99
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 14.99
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 14.99
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 14.96
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 14.89
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 14.84
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 14.84
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 14.84
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 14.82
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.8
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.8
H1609088 Human RNA-Sequencing 14.79
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 14.67
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 14.66
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 14.66
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 14.51
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 14.51
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 14.49
RNA-Sequencing of HepG2 cells treated with TGFBeta 14.45
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 14.4
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 14.38
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 14.33
TGF-β regulation of miRNA expression in pancreatic cancer 14.3
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 14.06
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 14.04
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 14.04
Gene Expression Profiling of SPOP Knocked Down Cell 14.02
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 13.78
Endometrial transcriptome and PGR cistrome in cycling fertile women 13.77
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 13.77
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 13.75
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 13.75
RNA-seq analysis of RALD iPSCs after in vitro differentiation 13.71
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 13.65
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 13.58
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 13.58
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 13.57
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 13.53
RNA transcriptome analysis during HSV-1 infection 13.51
Gene expression alterations of pancreatic intraepithlial neoplasia 13.47
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 13.27
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 13.24
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 13.22
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 13.18
Gene expression profile in breast cancer cell lines using RNA sequencing 13.15
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 13.09
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 13.09
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 13.07
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 12.98
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 12.95
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 12.95
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 12.92
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 12.9
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.63
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 12.63
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 12.61
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 12.6
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 12.58
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 12.56
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 12.45
Genome-wide analysis of Dengue virus 2 infected cells 12.18
PTHrP overexpression in MCF7 cells 12.18
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 12.04
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 11.99
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 11.88
Functional Haploid Human Oocytes Generated from Polar Body Genomes 11.85
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 11.85
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 11.8
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 11.69
hESC neural differentiation 11.66
RNA-seq analysis of gene expression patterns during hESC neural differentiation 11.66
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 11.56
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 11.54
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 11.47
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 11.32
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 11.3
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 11.24
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 11.23
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 11.21
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 11.2
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 11.09
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 11.08
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 11.02
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 11.01
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 10.9
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 10.86
circRNA profile in hypopharyngeal cancer 10.8
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 10.72
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 10.72
circNFIB suppresses lymphatic metastasis of pancreatic cancer 10.61
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 10.59
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 10.56
4sU-seq of HFF exposed to salt and heat stress 10.53
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 10.53
Capturing the Interactome of Newly Transcribed RNA (RICK) 10.48
Capturing the Interactome of Newly Transcribed RNA 10.48
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 10.46
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 10.45
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 10.42
RNA-seq of naive and primed ES cells 10.41
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 10.27
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 10.26
Conservative alteration of chromosomal expression pattern across human solid tumor types 10.18
Disruption of GRIN2B impairs differentiation in human neurons 10.13
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 10.11
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 10.11
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 10.04
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 10.02
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 10.02
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 9.62
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 9.62
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 9.61
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 9.6
Fusion discovery in breast cancer cell line 9.54
Reprogrammed myeloid cell transcriptomes in NSCLC 9.5
CHD1 regulates cell fate determination by activation of differentiation-induced genes 9.46
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 9.41
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 9.09
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 9.07
IRF1 regulates IFN dependent and independent gene expression 9.07
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 9.02
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 8.77
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 8.75
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 8.6
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 8.17
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 8.13
Expression profiles of the four human major ectodermal lineages 8.12
Functional astrocytes differentiated from hiPSCs 8.08
4sUDRB-seq: measuring transcription elongation and initiation genomewide 8.03
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 7.94
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 7.91
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 7.88
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 7.75
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 7.58
Gene expression changes in human melanoma cell lines compared to primary melanocytes 7.5
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 7.46
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 7.05
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 7.05
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 6.99
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 6.92
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 6.92
Redifferentiation of expanded human islet β cells by inhibition of ARX 6.91
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 6.88
Toxoplasma gondii infection of human retinal pigment epithelial cells 6.71
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 6.71
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 6.65
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 6.65
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.41
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.41
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 6.39
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 6.22
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 6.16
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 6.12
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 5.72
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 5.66
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 5.61
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 5.51
miR-93 Targets in Human Endothelial Cells 5.35
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 5.16
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 5.09
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.02
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.01
CDK4/6 inhibitor resistance in prostate cancer 4.99
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.97
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 4.91
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 4.91
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 4.89
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 4.52
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.26
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.24
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.94
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 3.9
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.89
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 3.86
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 3.81
Regulation of poly(A) tail and translation during the somatic cell cycle 3.58
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 3.58
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 3.53
Persistence of stem cell metabolism in cancers as a failure of differentiation 3.53
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 3.35
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 3.35
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.27
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 3.23
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 3.11
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 3.05
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 3.01
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 2.84
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.78
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 2.77
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.58
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 2.45
DAOY-Notch1/Notch2 knockout: transcriptome comparison 2.45
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 2.44
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 2.44
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.29
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.25
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.25
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 1.97
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 1.87
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.84
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.82
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.63
Gene expression analysis upon mtDNA depletion 1.63
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.62
RNA sequencing of GlyH-101-treated MCF-7 cell line 1.62
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 1.47
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 1.47
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.43
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.39
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 1.38
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 1.34
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 1.07
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 1.04
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.02
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.02
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 0.91
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 0.91
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.73
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.67
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.67
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 0.65
Dermal endothelial cells of type 2 diabetic patients 0.61
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.55
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.5
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 0.48
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.46
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.19
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.18
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.18
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.13
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation